Bekasi Asri Pemula Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Bekasi Asri Pemula Tbk trades at Rp240 (market cap 186.62B, 71.44M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,500 (market cap 11.36T, 200K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 60.9× Bekasi Asri Pemula Tbk's market cap, and Bekasi Asri Pemula Tbk is more actively traded (71.44M versus 200K). Which is the better fit depends on your goals.
| BAPA | TSPC | |
|---|---|---|
Market Cap | 186.62B | 11.36T |
Volume | 71.44M | 200K |
Lot | 714.38K | 2K |
Turnover | 18.3B | 500.06M |
Average Price | 256.12 | 2,500.28 |
Value | 18.3B | 500.06M |
Indicative Equilibrium Price | 240 | 2,500 |
Indicative Equilibrium Volume | 16.81K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bekasi Asri Pemula Tbk (the company) was established on 22 Oct 1993 based on Notaries Deed No. 909 and the deed of establishment was approved by the the Ministry of Justice dated Mar 11, 1994. The Company's articles of association has been amended several times, most recently by notarial deed No. 30 of Wijanto Suwongso, S.H., dated Feb 28, 2007, concerning among others, increase authorized, Paid up Capital and public offering.
Read more on BAPA →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →